Acutus Medical (NASDAQ:AFIB – Get Free Report) is expected to be issuing its results on Friday, November 13th. Analysts expect Acutus Medical to announce earnings of ($0.95) per share and revenue of $2.79 million for the quarter.
Acutus Medical Trading Up 9,900.0%
NASDAQ AFIB opened at $0.00 on Wednesday. Acutus Medical has a 12 month low of $0.00 and a 12 month high of $0.01. The company has a market cap of $2,991.20, a price-to-earnings ratio of -0.00 and a beta of 5.71.
About Acutus Medical
Acutus Medical, Inc. was a medical technology company focused on developing products for the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation. The company’s technologies were designed for use by cardiac electrophysiologists during minimally invasive catheter-based procedures. Its primary product platform was the AcQMap High Resolution Imaging and Mapping System, which combined ultrasound imaging with electrical mapping to create three-dimensional models of the heart and help physicians identify abnormal electrical activity.
Read More
- Five stocks we like better than Acutus Medical
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}